XML 37 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Collaboration arrangements and concentration of credit risk (Tables)
 9 Months Ended
Sep. 30, 2017
Collaboration arrangements and concentration of credit risk  
Schedule of collaboration and license revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30, 

 

Nine months ended September 30, 

 

    

2017

    

2016

    

2017

    

2016

 

 

in thousands

Bristol Myers Squibb

 

$

2,260

 

$

5,125

 

$

5,877

 

$

10,396

Chiesi Farmaceutici S.p.A

 

 

 —

 

 

2,096

 

 

4,646

 

 

5,571

Total

 

$

2,260

 

$

7,221

 

$

10,523

 

$

15,967

 

Schedule of amounts owed in relation to collaboration

 

 

 

 

 

 

 

 

 

September 30, 

 

December 31, 

 

    

2017

    

2016

 

 

in thousands

Bristol Myers Squibb

 

$

1,945

 

$

5,500

Chiesi Farmaceutici S.p.A

 

 

 —

 

 

3,680

Total

 

$

1,945

 

$

9,180